Gene Therapy Market: Top Growth Pockets Promising Industry Dominance 2022-2026

Gene therapy is being extensively used to treat several diseases like cancer, cystic fibroses, heart diseases, diabetes, AIDS, and Hemophilia. Increasing popularity of gene therapy owes to the provision of complete cure to patients affected with genetic and other life-threatening disorders. One of the major factors driving growth for the gene therapy market is the growing cancer cases on a global scale. Numerous gene therapy strategies have been developed. For example: oncolytic virotherapy, correction of gene defects, genetic manipulation of apoptotic and tumor invasion pathways, gene therapy-based immune modulation, and RNAi strategies. These treatments target cancers affecting lungs, brain, pancreas, skin, and ovaries


Onslaught of the COVID-19 pandemic has accelerated the application of gene therapy. Technology for gene and cell therapy is anticipated to be excessively applied for developing vaccines. In January 2      019, Mass General Brigham developed vaccine candidates which stimulated convincing immune responses from animal models in treatment of the novel coronavirus. The vaccine candidate named AAVCOVID, was developed through gene-therapy technology and received a grant of USD 2.1 Million for further research. Similarly, researchers from the University of Pennsylvania have started using adeno-associated viral vectors to transmit lab-made antibodies into the body.

 Looking For a Sample Copy of This Report? Request the Same Here:  https://www.fairfieldmarketresearch.com/report/gene-therapy-market/request-sample

Increasing Incidence of Cancer Facilitates Gene Therapy Market Growth

 Gene therapy encompasses an advanced medical treatment for numerous chronic and genetic disorders in humans. This is achieved by replacing a defective gene cell with a healthy gene cell. Through gene therapy, chronic and genetic disorders that do not have developed cures can be prevented. Developers of gene therapy are quickly expanding their businesses through acquisitions and mergers. New product launch deals are being signed as a strategy to strengthen product trails and augment in-house proficiency.

Researchers are increasingly finding investments to enhance the process of transferring genes into cancer cells. The carrier that takes genes into cancer cells is called a vector. Viruses can enter cells and deliver genetic material once they are altered in a way that cannot result in any serious disorder. Therefore, they are the most common types of carriers used in gene therapy. Due to these factors, the market for gene therapy is expected to experience a sturdy growth.

 Do You Have Any Query or Specific Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/gene-therapy-market/request-customization

 North America Forecasted to Dominate Global Gene Therapy Market

 The US Department of Health and Human Services has been appointed to oversee clinical trials of gene therapy. These treatments have been securing approvals from government organizations like the US FDA, OHRP, and CFR. Increasing developments in gene therapy strategies in the United States of America is augmenting the market growth in the North American region. Big pharma companies are collaborating and initiating acquisitions in order to cash in on these growing opportunities.

 The global gene therapy market consists of a few key players. Major companies hold a considerable collective share in the global market. These include Uniqure NV, Orchard Therapeutics, Spark Therapeutics (Roche AG), Sibiono GeneTech, Novartis AG, Bluebird Bio, Gilead Sciences inc., and Amgen inc.

 About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

 Contact

Fairfield Market Research

London, UK

UK +44 (0)20 30025888   

USA (Toll-free) +1 (844) 3829746 

Web: https://www.fairfieldmarketresearch.com/

Email: sales@fairfieldmarketresearch.com

Follow Us: LinkedIn

 

 

Comments

Post a Comment

Popular posts from this blog

Economic Realignment: Forecasting the Clear Aligners Market (2023 - 2029)

Image
 The global market for clear aligners is currently having a significant impact on the dentistry sector in addition to building a solid reputation for itself. Between 2023 and 2029, Clear Aligners are expected to rise at a staggering 19.8% annual pace, revolutionizing orthodontic treatment and surpassing a market value of US$23.8 billion. Clear aligners have revolutionized the field of dentistry by providing a more useful, comfortable, and aesthetically appealing alternative to traditional metal braces. The World Health Organization considers malocclusions as the third-biggest oral health problem, behind periodontal disease and cavities, and they are now the preferred way of treatment. For more information, please refer to the full report: https://www.fairfieldmarketresearch.com/report/clear-aligners-market Unmasking the Potential: The Rising Demand for Efficient Dental Care With aesthetic appeal and functionality at the forefront, effective orthodontic treatments like clear ...
Read more

Acute Lung Injury Treatment Market Growth and key Industry Players, 2022 Analysis and Forecast

Image
  global Acute lung injury treatment market owing to the high prevalence of lung-related diseases & leading causes of morbidity among critically-ill patients worldwide. These disorders have a high fatality rate as a disrupted supply of oxygen can have adverse side effects on the body. Restricted oxygen supply to the brain can lead to cardiac arrest which has a survival rate of less than 10%. The grave nature of acute lung injury has increased the demand for effective treatments to mitigate associated risks. Prominent industry players in the acute lung injury treatment market are investing significantly to develop advanced treatments and therapies against acute lung injury. In the foreseeable future, this business landscape is anticipated to create headways for growth in the global acute lung injury treatment market, with a special focus on healthcare innovation, M&A, and aggressive R&D across international markets.   Looking For a Sample Copy of This Report? Req...
Read more

KSA Medical Devices Market Projects Strong Growth, Reaching US$2 Billion in 2022

Image
The KSA Medical Devices Market, which registered a valuation of US$2 billion in 2022, anticipates witnessing a promising pace of growth in the coming years. This expansion is spurred by significant shifts towards homecare settings, the escalating prevalence of chronic diseases, and the growing demand for cost-effective healthcare services outside hospitals. For more information, please refer to the full report: https://www.fairfieldmarketresearch.com/report/ksa-medical-devices-market   / The KSA market also opens up opportunities for the rising preference for wearable devices and the requirement for enhanced healthcare monitoring during emergencies. Fitness trackers are rapidly gaining popularity among consumers, and the continuous monitoring provided by these devices can significantly improve healthcare outcomes during crises. "The move towards homecare solutions is dramatically changing the healthcare landscape," says a top market analyst. "The demand for speci...
Read more